Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGA| |CCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAA
End
227537329/226672613 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/13820; hsa-mir-1244-1/Downstream/799519;
Upstream sequence
ggatcccttgaacccagaaggtcaaggctataatgagatttggttgcaccattgcactccagccttggtgatagagggagaccctgtctcgaaaaaGATG
Downstream sequence
CAAGTCTACAACGGAACAGAGGATTAAAATGATATTTAACCTGTGAATTCAAAACTTCTACTTCCCATTTTAATTTGTAAGGGCTTAGGAGGAGGAGGAA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.